No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation

scientific article published on 01 January 2019

No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3389/FPHAR.2019.01686
P932PMC publication ID7045476
P698PubMed publication ID32153387

P2093author name stringRong Hu
Benedetta C Sallustio
Andrew A Somogyi
Daniel T Barratt
Janet K Coller
P2860cites workNF-kappaB regulation in the immune systemQ28205043
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytesQ28237565
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristicsQ28338447
Negative regulation of toll-like receptor-mediated immune responsesQ29619019
Functional analysis of the C-reactive protein (CRP) gene -717A>G polymorphism associated with coronary heart diseaseQ33485550
Identification of a monocyte specific pre-interleukin 1 beta convertase activityQ34289070
Lack of Association between Interleukin-10 Gene Polymorphisms and Graft Rejection Risk in Kidney Transplantation Recipients: A Meta-AnalysisQ35649843
Routes to transplant tolerance versus rejection; the role of cytokines.Q35671669
Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal FentanylQ35762509
Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damageQ36536931
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritisQ37385249
Association Between Cytokines and Their Receptor Antagonist Gene Polymorphisms and Clinical Risk Factors and Acute Rejection Following Renal Transplantation.Q37481658
Patterns of Early Rejection in Renal Retransplantation: A Single-Center Experience.Q37531788
The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunityQ37583889
Rejection of the kidney allograftQ37798268
The pro- and anti-inflammatory properties of the cytokine interleukin-6.Q37836084
Donor or recipient TNF-A -308G/A polymorphism and acute rejection of renal allograft: A meta-analysisQ37876524
Association between IL-6 -174G/C polymorphism and acute rejection of renal allograft: evidence from a meta-analysisQ37949193
Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosisQ38206875
Interleukin-6 and its receptors: a highly regulated and dynamic systemQ38225453
T-cell growth factors: interleukin 2.Q38257634
Association Between Interleukin-2 -330 T/G Polymorphism and Acute Renal Graft Rejection: A Meta-analysisQ38570446
Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitisQ39556021
Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism.Q40000036
Banff 07 classification of renal allograft pathology: updates and future directionsQ40121163
Interleukin-10-1082 G/a polymorphism and acute renal graft rejection: a meta-analysisQ40366915
The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.Q41117030
Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV diseaseQ42252891
Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.Q44178678
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.Q44443237
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER studyQ46729948
Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantationQ46875615
Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta proteinQ47368325
Ethnicity-dependent influence of innate immune genetic markers on morphine PCA requirements and adverse effects in postoperative painQ47377458
Association of innate immune single-nucleotide polymorphisms with the electroencephalogram during desflurane general anaesthesiaQ47935662
An investigation of polymorphism in the interleukin-10 gene promoterQ48054541
Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver TransplantationQ50218047
Donor cytokine genotype influences the development of acute rejection after renal transplantation.Q52067391
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post Kidney Transplantation.Q52617445
Association of functional genetic variants of transcription factor Forkhead Box P3 and Nuclear Factor-κB with end-stage renal disease and renal allograft outcome.Q53640107
Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients.Q53654083
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationQ54022204
Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.Q54612295
Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced.Q54706157
The impact of recipient cytokine genotype on acute rejection after renal transplantationQ73299678
Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytesQ77090329
Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantationQ77531558
Genetic control of the circulating concentration of transforming growth factor type beta1Q77789926
Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcomeQ79947859
Incidence of donor and recipient toll-like receptor-4 polymorphisms in kidney transplantationQ79959693
Analysis of cytokine gene polymorphisms in recipient's matched with living donors on acute rejection after renal transplantationQ80424463
Influence of cytokine gene polymorphisms on graft rejection in Turkish patients with renal transplants from living related donorsQ84289046
Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipientsQ84307822
Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot studyQ85798378
The impact of liver transplant recipient and donor genetic variability on tacrolimus exposure and transplant outcomeQ92895574
Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?Q93157288
Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantationQ93390510
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P304page(s)1686
P577publication date2019-01-01
P1433published inFrontiers in PharmacologyQ2681208
P1476titleNo Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation
P478volume10

Search more.